New Delhi [India], May 27: Shares of Park Medi World remained in focus after brokerage firm Choice Broking reiterated its ‘buy’ rating on the healthcare player and projected nearly 20% upside from current levels, citing aggressive expansion plans, improving margins, and strong financial health.
In its latest report, the brokerage revised its target price on Park Medi World to ₹350 per share, highlighting multiple growth levers for the hospital chain. According to the brokerage, the company’s expansion strategy, efficient capital deployment, richer case mix, optimised average length of stay (ALOS), better payor mix, and benefits from revised CGHS rates are expected to support future earnings growth.
The management, during an interaction with the brokerage, indicated that revenues are expected to scale up to nearly ₹1,400 million by the second year, marking around 40% year-on-year growth. EBITDA is projected to rise to ₹35 million with margins of 25%, while profit after tax is estimated at ₹21 million with a 15% margin, aided by occupancy levels improving to 70–75%.
Choice Broking said the company’s confidence stems from strong promoter commitment, healthy balance sheet strength, and proven execution capabilities. The brokerage also noted that Park Medi World turned debt-free in February 2026 and continues to generate healthy operating cash flows, giving it significant financial flexibility to pursue expansion opportunities.
The bullish outlook comes after the company reported a strong operational and financial performance for the March quarter.
Get Featured Today!
Get featured your news, press release, success story and more on The Bizz Stories. You can feature on Article, Social Media Post, Biography and more.
Park Medi World posted a 58% year-on-year rise in consolidated net profit attributable to owners of the company at ₹70.9 crore for Q4 FY26, compared with ₹44.8 crore in the corresponding quarter last year.
Consolidated profit after tax increased 47% YoY to ₹76.8 crore from ₹52.4 crore, while revenue from operations climbed 30% to ₹460.4 crore against ₹353.9 crore in the year-ago period.
At the operating level, EBITDA surged 44% YoY to ₹127.4 crore. EBITDA margins expanded sharply to 27.7% from 25.0% a year earlier, reflecting improved operational efficiencies and stronger operating leverage.
The company also accelerated its expansion strategy during FY26. According to its exchange filing, Park Medi World added 610 beds during the year, resulting in a 20% increase in capacity. The expansion was driven by acquisitions in Bhatinda with 250 beds and Agra with 360 beds, taking the total bed capacity to 3,610 as of March 31, 2026.
The newly listed healthcare stock has also delivered strong returns to investors since its market debut. Park Medi World shares, which were listed at ₹158.80 apiece in December 2025, are currently trading nearly 80% above their listing price.
On the bourses, the stock has emerged as a strong performer in the healthcare space, rallying almost 90% on a year-to-date basis. The counter has gained around 11% over the past week and more than 20% in the last month alone, reflecting sustained investor optimism around the company’s expansion-led growth story.
rss_feed
Disclaimer
This is an unedited and auto-generated story from Syndicated News feed, The Bizz Stories Staff may not have modified or edited the content body.
favorite
Follow us for the latest updates:
PNN Verified Media or Organization • 25 Apr, 2026Agency
(This is an unedited and auto-generated story from Syndicated News feed, TBS Staff may not have modified or edited the content body)
.jpg)
.jpg)
.jpeg)
